NYSE: CATX - Perspective Therapeutics, Inc.

Lønnsomhet i seks måneder: -69.59%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Perspective Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc.

flere detaljer
and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2005-11-10
ISIN US46489V1044
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.perspectivetherapeutics.com
Цена ао 1.24
Prisendring per dag: -3.04% (3.29)
Prisendring per uke: +11.93% (2.85)
Prisendring per måned: -22.57% (4.12)
Prisendring over 3 måneder: -74.62% (12.57)
Prisendring over seks måneder: -69.59% (10.49)
Prisendring per år: +697.5% (0.4)
Prisendring over 3 år: +659.52% (0.42)
Prisendring over 5 år: +608.89% (0.45)
Prisendring over 10 år: 0% (3.19)
Prisendring siden begynnelsen av året: -70.1% (10.67)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 133.02 1
P/BV 17.29 1
P/E 0 0
EV/EBITDA -62.27 0
Total: 0.875

Effektivitet

Navn Betydning Karakter
ROA, % -25.25 0
ROE, % -26.85 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.1163 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -2.68 0
Lønnsomhet Ebitda, % 179.96 10
Lønnsomhet EPS, % 42.79 6
Total: 7.2
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 13213750 2.25
Baker Brothers Advisors, LLC 7639703 1.3
Blackrock Inc. 4538389 0.77
Geode Capital Management, LLC 2516649 0.43
Ghost Tree Capital, LLC 1600000 0.27
Osterweis Capital Management, Inc. 1582100 0.27
HighTower Advisors, LLC 1332238 0.23
Perkins Capital Management, Inc. 700000 0.12
State Street Corporation 671524 0.11
Taylor & Morgan Wealth Management, LLC 625000 0.11

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Russell 2000 Growth ETF 0.04295 38.04 0.6026
iShares Morningstar Small-Cap Growth ETF 0.02697 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.02697 587.89 0.72598
iShares Morningstar Small-Cap ETF 0.01351 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.01351 391.25 1.60498
iShares Russell 3000 ETF 0.00132 24.83 1.43482



Veileder Stillingstittel Betaling Fødselsår
Mr. Johan M. Spoor CEO & Director 855.78k 1972 (53 år)
Mr. Jonathan R. Hunt CFO and Principal Financial & Accounting Officer 944.35k 1967 (58 år)
Mr. Shane Cobb Executive Vice President of Operations N/A
Dr. Michael K. Schultz Ph.D. Chief Science Officer N/A
Mr. Andrew Bright Executive Vice President of Brachytherapy N/A
Dr. Markus Puhlmann M.B.A., M.D. Chief Medical Officer 633.14k 1966 (59 år)
Mr. Amos Hedt BA, PGradDip Chief Business Strategy Officer N/A
Dr. Frances L. Johnson M.D. Chief Innovation Officer N/A
Mr. David Hauser Ph.D. Senior Vice President of Clinical Operations N/A
Steve Keefe Senior Vice President of Clinical Development

Adresse: United States, Richland. WA, 350 Hills Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.perspectivetherapeutics.com